RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 137 filers reported holding RELAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $95,062 | -55.6% | 14,580 | -43.4% | 0.00% | – |
| Q1 2024 | $213,933 | -29.7% | 25,775 | -6.8% | 0.00% | – |
| Q4 2023 | $304,482 | +18.8% | 27,655 | -9.2% | 0.00% | – |
| Q3 2023 | $256,203 | -21.4% | 30,464 | +17.4% | 0.00% | – |
| Q2 2023 | $326,020 | -25.9% | 25,957 | -2.8% | 0.00% | – |
| Q1 2023 | $439,881 | +24.3% | 26,708 | +12.7% | 0.00% | – |
| Q4 2022 | $353,899 | -23.4% | 23,688 | +14.7% | 0.00% | – |
| Q3 2022 | $462,000 | +65.0% | 20,648 | +23.3% | 0.00% | – |
| Q2 2022 | $280,000 | -58.4% | 16,749 | -25.5% | 0.00% | – |
| Q1 2022 | $673,000 | -2.2% | 22,472 | +0.3% | 0.00% | – |
| Q4 2021 | $688,000 | -27.7% | 22,400 | -25.8% | 0.00% | -100.0% |
| Q3 2021 | $952,000 | -12.8% | 30,176 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $1,092,000 | +262.8% | 29,850 | +243.0% | 0.00% | – |
| Q1 2021 | $301,000 | +5.6% | 8,703 | +27.0% | 0.00% | – |
| Q4 2020 | $285,000 | – | 6,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |